MRSN Current Ratio

The Current Ratio of Mersana Therapeutics Inc (MRSN) is 2.19.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

MRSN Current Ratio - Historical Value

Date	Value
2024-12-31	2.19
2023-12-31	3.36
2022-12-31	3.49
2021-12-31	3.98
2020-12-31	8.62
2019-12-31	4.20
2018-12-31	1.07
2017-12-31	3.68
2016-12-31	3.60
2015-12-31	1.20

MRSN Current Ratio - Peers Comparison

Ticker	Name	Value
950200.KQ	Psomagen Inc	1.67
AMGN	Amgen Inc	1.14
AVXL	Anavex Life Sciences Corp	11.60
ARCT	Arcturus Therapeutics Holdings Inc	6.64
BTAI	BioXcel Therapeutics Inc	0.83
CYDY	Cytodyn Inc	0.26
EPIX	ESSA Pharma Inc	38.79
PRTA	Prothena Corporation PLC	7.72
AFMD	Affimed NV	3.25
DVAX	Dynavax Technologies Corp	10.80
GILD	Gilead Sciences, Inc.	1.55
PASG	Passage Bio Inc	2.07
ALGS	Aligos Therapeutics, Inc.	3.90
ORIC	ORIC Pharmaceuticals, Inc.	14.13
TRIL.TO	Trillium Therapeutics Inc	13.95
VRTX	Vertex Pharmaceuticals Incorporated	2.90
ADAP	Adaptimmune Therapeutics PLC	2.92
ANNX	Annexon, Inc.	5.68
PRAX	Praxis Precision Medicines, Inc.	10.22
RYTM	Rhythm Pharmaceuticals, Inc.	4.41
950160.KQ	Kolon TissueGene Inc	0.24
REGN	Regeneron Pharmaceuticals, Inc.	4.13
ATRA	Atara Biotherapeutics, Inc.	0.82
FDMT	4D Molecular Therapeutics Inc	9.39
SNDX	Syndax Pharmaceuticals, Inc.	4.40
TSHA	Taysha Gene Therapies, Inc.	12.23
CRTX	Cortexyme Inc	7.85
EPZM	Epizyme Inc	4.56
ITOS	iTeos Therapeutics Inc	12.75
KNSA	Kiniksa Pharmaceuticals International, PLC	3.79
950220.KQ	Neoimmunetech Inc	3.08
ABBV	AbbVie Inc.	0.67
ADVM	Adverum Biotechnologies Inc	5.73
AKRO	Akero Therapeutics Inc	19.25
MRNA	Moderna, Inc.	3.29
NWBO	Northwest Biotherapeutics Inc	0.06
PCVX	Vaxcyte, Inc.	7.91